ClinicalTrials.Veeva

Menu

Construction of a Database for TMA

S

Soochow University

Status

Enrolling

Conditions

Thrombotic Microangiopathies

Treatments

Other: collection data

Study type

Observational

Funder types

Other

Identifiers

NCT05634928
SOOCHOW-HY-2022-13

Details and patient eligibility

About

Information about patients was collected by reviewing the Hitech case system and telephone and outpatient follow-up, and the case database was constructed by Epidata software. The sample size is expected to be 200 cases, the participating hospital is the First Affiliated Hospital of Soochow University, and the study time frame is from Dec 1, 2022, to Nov 31, 2027. The observation indexes of the study include the basic information of patients' age and gender and the clinical-related data of thrombotic microangiopathy.

Enrollment

500 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • The patient has elevated lactate dehydrogenase to more than twice the baseline value, platelets less than 20 or decreased by more than 50% within 24 hours, and more than 2% of schistocytes visible on a peripheral blood smear. Alternatively, pathological sections show extensive micro thrombosis.

Exclusion criteria

  • The investigator considers the subject unable or unwilling to cooperate with the study procedures.

Trial design

500 participants in 1 patient group

TMA
Description:
TMA patients
Treatment:
Other: collection data

Trial contacts and locations

1

Loading...

Central trial contact

Yue Han, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems